Advances in Prophylaxis for Recurrent Urinary Tract Infections in Women

doi:10.12114/j.issn.1007-9572.2019.00.189

Abstract

Abstract: Urinary tract infections（UTIs）are common bacterial infections that are recurrent easily in females.However，how to prevent and reduce the recurrence of UTIs in women remains a focus and challenge in clinical medicine.This article summarizes the existing preventive measures and advances in recurrent UTIs in women，and proposes the prevention strategies such as changing living habits，using estrogen locally after menopause，using probiotics，vaccinating，etc.，in addition to the preventive use of antibiotics，so as to provide effective references and suggestions for further preventive and treatment approaches for UTIs in women.

Key words: Urinary tract infections, Femininity, Prophylaxis, Recurrence, Review

摘要： 女性尿路感染是常见的细菌感染性疾病，易复发，如何预防及减少女性尿路感染复发是目前临床医学研究的重点及难点。本文总结了女性复发性尿路感染现有的预防措施及进展，提出除了预防性使用抗生素外还有改变生活习惯、绝经后局部使用雌激素、使用益生菌、接种疫苗等预防策略，对未来寻求预防及治疗女性尿路感染的途径提供了有效的参考及建议。

关键词: 泌尿道感染, 女性, 预防, 复发, 综述

ZHANG Yu,HUANG Wenxiang,JIA Bei. Advances in Prophylaxis for Recurrent Urinary Tract Infections in Women　[J]. Chinese General Practice, 2020, 23(3): 369-372. DOI: 10.12114/j.issn.1007-9572.2019.00.189.
张雨,黄文祥,贾蓓. 预防女性复发性尿路感染策略研究进展[J]. 中国全科医学, 2020, 23(3): 369-372. DOI: 10.12114/j.issn.1007-9572.2019.00.189.

References

［1］FOXMAN B.Epidemiology of urinary tract infections：incidence，morbidity，and economic costs［J］．Dis Mon，2003，49（2）：53-70．DOI：10.1067/mda.2003.7.
［2］FOXMAN B，GILLESPIE B，KOOPMAN J，et al．Risk factors for second urinary tract infection among college women［J］．Am J Epidemiol，2000，151（12）：1194-1205.
［3］FOXMAN B，BROWN P.Epidemiology of urinary tract infections：transmission and risk factors，incidence，and costs［J］．Infect Dis Clin North Am，2003，17（2）：227-241.
［4］RAZ R，GENNESIN Y，WASSER J，et al．Recurrent urinary tract infections in postmenopausal women［J］．Clin Infect Dis，2000，30（1）：152-156．DOI：10.1086/313596.
［5］FOXMAN B.Urinary tract infection syndromes：occurrence，recurrence，bacteriology，risk factors，and disease burden［J］．Infect Dis Clin North Am，2014，28（1）：1-13．DOI：10.1016/j.idc.2013.09.003.
［6］LLOR C，BJERRUM L.Antimicrobial resistance：risk associated with antibiotic overuse and initiatives to reduce the problem［J］．Ther Adv Drug Saf，2014，5（6）：229-241．DOI：10.1177/2042098614554919.
［7］HOOTON T M，VECCHIO M，IROZ A，et al．Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections：a randomized clinical trial［J］．JAMA Intern Med，2018，178（11）：1509-1515．DOI：10.1001/jamainternmed.2018.4204.
［8］TIAN Y，CAI X，WAZIR R，et al．Water consumption and urinary tract infections：an in vitro study［J］．Int Urol Nephrol，2016，48（6）：949-954．DOI：10.1007/s11255-016-1262-7.
［9］SCHOLES D，HOOTON T M，ROBERTS P L，et al．Risk factors for recurrent urinary tract infection in young women［J］．J Infect Dis，2000，182（4）：1177-1182．DOI：10.1086/315827.
［10］HANDLEY M A，REINGOLD A L，SHIBOSKI S，et al．Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides［J］．Epidemiology，2002，13（4）：431-436.
［11］FIHN S D，BOYKO E J，CHEN C L，et al．Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus［J］．Arch Intern Med，1998，158（3）：281-287.
［12］AL DEMOUR S，ABABNEH M A.Evaluation of behavioral and susceptibility patterns in premenopausal women with recurrent urinary tract infections：a case control study［J］．Urol Int，2018，100（1）：31-36．DOI：10.1159/000485568.
［13］NICOLLE L E，RONALD A R.Recurrent urinary tract infection in adult women：diagnosis and treatment［J］．Infect Dis Clin North Am，1987，1（4）：793-806.
［14］RONALD A R，CONWAY B.An approach to urinary tract infections in ambulatory women［J］．Curr Clin Top Infect Dis，1988，9：76-125.
［15］STAMM W E，HOOTON T M.Management of urinary tract infections in adults［J］．N Engl J Med，1993，329（18）：1328-1334．DOI：10.1056/NEJM199310283291808.
［16］ALBERT X，HUERTAS I，PEREIRó I I，et al．Antibiotics for preventing recurrent urinary tract infection in non-pregnant women［J］．Cochrane Database Syst Rev，2004（3）：CD001209．DOI：10.1002/14651858.CD001209.pub2.
［17］AHMED H，DAVIES F，FRANCIS N，et al．Long-term antibiotics for prevention of recurrent urinary tract infection in older adults：systematic review and meta-analysis of randomised trials［J］．BMJ Open，2017，7（5）：e015233．DOI：10.1136/bmjopen-2016-015233.
［18］AHMED H，FAREWELL D，JONES H M，et al．Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection：cohort study［J］．Age Ageing，2018．［Epub ahead of print］．DOI：10.1093/ageing/afy146．
［19］SMITH A L，BROWN J，WYMAN J F，et al．Treatment and prevention of recurrent lower urinary tract infections in women：a rapid review with practice recommendations［J］．J Urol，2018，200（6）：1174-1191．DOI：10.1016/j.juro.2018.04.088.
［20］MELEKOS M D，ASBACH H W，GERHARZ E，et al．Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women［J］．J Urol，1997，157（3）：935-939.
［21］STAPLETON A，LATHAM R H，JOHNSON C，et al．Postcoital antimicrobial prophylaxis for recurrent urinary tract infection.A randomized，double-blind，placebo-controlled trial［J］．JAMA，1990，264（6）：703-706.
［22］WONG E S，MCKEVITT M，RUNNING K，et al．Management of recurrent urinary tract infections with patient-administered single-dose therapy［J］．Ann Intern Med，1985，102（3）：302-307.
［23］SCHAEFFER A J，STUPPY B A.Efficacy and safety of self-start therapy in women with recurrent urinary tract infections［J］．J Urol，1999，161（1）：207-211.
［24］GUPTA K，HOOTON T M，ROBERTS P L，et al．Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women［J］．Ann Intern Med，2001，135（1）：9-16.
［25］BEEREPOOT M A，TER RIET G，NYS S，et al．Lactobacilli vs antibiotics to prevent urinary tract infections：a randomized，double-blind，noninferiority trial in postmenopausal women［J］．Arch Intern Med，2012，172（9）：704-712．DOI：10.1001/archinternmed.2012.777.
［26］BEEREPOOT M A，GEERLINGS S E，VAN HAARST E P，et al．Nonantibiotic prophylaxis for recurrent urinary tract infections：a systematic review and meta-analysis of randomized controlled trials［J］．J Urol，2013，190（6）：1981-1989．DOI：10.1016/j.juro.2013.04.142.
［27］RAZ R，STAMM W E.A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections［J］．N Engl J Med，1993，329（11）：753-756．DOI：10.1056/NEJM199309093291102.
［28］STAMM W E.Estrogens and urinary-tract infection［J］．J Infect Dis，2007，195（5）：623-624．DOI：10.1086/511526.
［29］FALAGAS M E，BETSI G I，TOKAS T，et al．Probiotics for prevention of recurrent urinary tract infections in women：a review of the evidence from microbiological and clinical studies［J］．Drugs，2006，66（9）：1253-1261．DOI：10.2165/00003495-200666090-00007.
［30］STAPLETON A E，AU-YEUNG M，HOOTON T M，et al．Randomized，placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection［J］．Clin Infect Dis，2011，52（10）：1212-1217．DOI：10.1093/cid/cir183.
［31］BARRONS R，TASSONE D.Use of Lactobacillus probiotics for bacterial genitourinary infections in women：a review［J］．Clin Ther，2008，30（3）：453-468．DOI：10.1016/j.clinthera.2008.03.013.
［32］LEE B S B，BHUTA T，SIMPSON J M，et al．Methenamine hippurate for preventing urinary tract infections［J］．Cochrane Database of Systematic Reviews，2012，10：CD003265．DOI：10.1002/14651858.cd003265.pub3.
［33］MAGISTRO G，STIEF C G.Vaccine development for urinary tract infections：where do we stand?［J］．Eur Urol Focus，2019，5（1）：39-41．DOI：10.1016/j.euf.2018.07.034.
［34］HOPKINS W J，ELKAHWAJI J，BEIERLE L M，et al．Vaginal mucosal vaccine for recurrent urinary tract infections in women：results of a phase 2 clinical trial［J］．J Urol，2007，177（4）：1349-1353．DOI：10.1016/j.juro.2006.11.093.
［35］BAUER H W，ALLOUSSI S，EGGER G，et al．A long-term，multicenter，double-blind study of an Escherichia coli extract（OM-89）in female patients with recurrent urinary tract infections［J］．Eur Urol，2005，47（4）：542-548；discussion 548．DOI：10.1016/j.eururo.2004.12.009.
［36］HICKLING D R，NITTI V W.Management of recurrent urinary tract infections in healthy adult women［J］．Rev Urol，2013，15（2）：41-48.
［37］OCHOA-BRUST G J，FERNáNDEZ A R，VILLANUEVA-RUIZ G J，et al．Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy［J］．Acta Obstet Gynecol Scand，2007，86（7）：783-787．DOI：10.1080/00016340701273189.
［38］CARLSSON S，GOVONI M，WIKLUND N P，et al．In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria［J］．Antimicrob Agents Chemother，2003，47（12）：3713-3718.
［39］WELLENS A，GAROFALO C，NGUYEN H，et al．Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex［J］．PLoS One，2008，3（4）：e2040．DOI：10.1371/journal.pone.0002040.
［40］ALTARAC S，PAPE? D.Use of d-mannose in prophylaxis of recurrent urinary tract infections（UTIs）in women［J］．BJU Int，2014，113（1）：9-10．DOI：10.1111/bju.12492.
［41］KRANJCEC B，PAPE? D，ALTARAC S.D-mannose powder for prophylaxis of recurrent urinary tract infections in women：a randomized clinical trial［J］．World J Urol，2014，32（1）：79-84．DOI：10.1007/s00345-013-1091-6.

[1]	ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019.
[2]	ZHA Qianqian, XU Lianying, CHEN Juan, HUANG Wen, ZHANG Xinqiong. Summary of Best Evidence for Prevention of Recurrence of Late-life Depression [J]. Chinese General Practice, 2023, 26(19): 2332-2338.
[3]	WANG Xin, ZHAO Ruibin, YANG Huafang, LIU Chong, LIU Tian, LU Cui, CHEN Didi. Phenotypic Characteristics and Recurrence Factors of MOG-IgG Associated Disorders in Children [J]. Chinese General Practice, 2023, 26(18): 2244-2249.
[4]	ZHANG Lulu, CHEN Huan, LUO Huan, CHEN Tingting, CHEN Xinyu, GAO Jing. Fear of Cancer Recurrence Assessment Tools Based on COSMIN: a Systematic Review [J]. Chinese General Practice, 2023, 26(17): 2138-2146.
[5]	WANG Gang, YUE Rensong, GONG Guangming. A Case-control Study of Risk Factors for Recurrence of Diabetic Foot Ulcer after Complete Healing [J]. Chinese General Practice, 2023, 26(15): 1857-1862.
[6]	YAO Huihui, SHU Lin, YAO Linli, LI Sha, YANG Xiaotong, LI Yunchun. Sex-specific Analysis of Influencing Factors for the Association between Baseline Serum Uric Acid and Two-year Outcome after First Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(05): 557-562.
[7]	ZENG Zhigang, ZHENG Shimin, CHEN Xiaofen, MA Juan. Therapeutic Effect of Huazhi Suppository Combined with Cap-assisted Endoscopic Sclerotherapy on Internal Hemorrhoids [J]. Chinese General Practice, 2022, 25(35): 4412-4417.
[8]	SHEN Dingyi, LI Xiaopan, MENG Fanping, LU Jingjue, ZHOU Yixin, LYU Jun. Death Status and Trends of Female Mental Disorders Patients in Pudong New Area of Shanghai, 2005-2021 [J]. Chinese General Practice, 2022, 25(32): 4072-4078.
[9]	Kai ZHANG, Caizhen WANG, Kang LIU, Suzhen SUN. Clinical Features and Recurrence-related Factors of Anti-N-methyl-D-aspartate Receptor Encephalitis in Children [J]. Chinese General Practice, 2022, 25(21): 2629-2634.
[10]	Yike JIAO, Li JING, Yuanmeng TIAN, Xinbin HAO, Weizhong WANG, Chengguang SONG, Qun SUN, Lei SHI, Jixu SUN, Xiaoxia AN, Liying XING, Zuosen YANG. Recurrence Status and Combined Risk Factors of Surviving Stroke Patients Aged Over 40 in Urban Areas [J]. Chinese General Practice, 2022, 25(18): 2244-2248.
[11]	Liyanran YAN, Yaqian WANG, Rina WU, Tianran CHEN, Xueli ZHANG. Factors Associated with Compliance and Association between Compliance and Recurrence in Patients with Acute Pancreatitis [J]. Chinese General Practice, 2022, 25(12): 1512-1518.
[12]	CHEN Xiaofeng, WANG Meng, LI Zhongyu, LI Jiajia. Clinical Study of Venetoclax with Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia [J]. Chinese General Practice, 2022, 25(08): 957-962.
[13]	TANG Yangming, SHI Renzhou, LAN Mei, LI Xuejun, WEN Zonghua, LU Xiaochen. Lenalidomideas a Second-line Therapy Achieves Long-term Remission in Elderly Patients with Relapsed/Refractory Multicentric Castleman's Disease：a Report of Two Cases and Literature Review [J]. Chinese General Practice, 2022, 25(03): 368-372.
[14]	LI Tingting，WANG Cuifeng. High Risk HPV Test Combined with TCT in the Screening of Cervical Intraepithelial Neoplasia　 [J]. Chinese General Practice, 2021, 24(9): 1106-1110.
[15]	YE Haichun, YAN Yajie, WANG Quan. Prevalence and Associated Factors of Depression among Middle-aged and Elderly Women　 [J]. Chinese General Practice, 2021, 24(36): 4574-4579.